CDC panel recommends Merck RSV shot for infants
TL;DR Summary
The CDC's vaccine advisory panel recommended Merck's RSV shot, Enflonsia, for infants under 8 months, marking a significant step in RSV prevention despite some safety concerns from critics. The vaccine, approved by the FDA, aims to reduce RSV-related hospitalizations and will be included in recommended childhood immunizations, competing with Sanofi and AstraZeneca's Beyfortus.
- RFK Jr.'s CDC vaccine panel backs Merck RSV shot for infants CNBC
- New CDC vaccine advisers vote to recommend Merck RSV antibody protection for babies CNN
- In surprise move, RFK Jr.'s vaccine committee votes to recommend RSV shot for infants USA Today
- CDC vaccine advisory panel to study child immunization schedule, recommends RSV shot for babies ABC News - Breaking News, Latest News and Videos
- RFK Jr.'s vaccine advisors recommend RSV antibodies for infants Axios
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
89%
500 → 53 words
Want the full story? Read the original article
Read on CNBC